Hirotaka Nishikiori

Sapporo, 0608543, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Targeting driver mutations in lung cancer with interstitial pneumonia: A nationwide study in Japan.

Targeting driver mutations in lung cancer with interstitial pneumonia: A nationwide study in Japan.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 18, 2025

Long-term changes and risk factors for persistent cough and sputum in adult patients with asthma treated by Japanese specialists: The SARAS study (1997-2023).

Long-term changes and risk factors for persistent cough and sputum in adult patients with asthma treated by Japanese specialists: The SARAS study (1997-2023).

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: October 05, 2025

Screening for lung fibrosis using serum surfactant protein-D, KL-6, and a deep learning algorithm on chest radiographs: a prospective observational study.

Screening for lung fibrosis using serum surfactant protein-D, KL-6, and a deep learning algorithm on chest radiographs: a prospective observational study.

Journal: BMC pulmonary medicine

Published: September 11, 2025

Prognosis and prognostic factors for chronic fibrosing idiopathic interstitial pneumonias.

Prognosis and prognostic factors for chronic fibrosing idiopathic interstitial pneumonias.

Journal: Respiratory investigation

Published: March 09, 2025

Exploring the Potential of a P2X3 Receptor Antagonist: Gefapixant in the Management of Persistent Cough Associated with Interstitial Lung Disease.

Exploring the Potential of a P2X3 Receptor Antagonist: Gefapixant in the Management of Persistent Cough Associated with Interstitial Lung Disease.

Journal: Medicina (Kaunas, Lithuania)

Published: February 16, 2025

Efficacy of nivolumab + ipilimumab ± chemotherapy versus pembrolizumab + chemotherapy in patients with PD-L1-negative non-small cell lung cancer (START001 PART-B): a multicenter retrospective observational study.

Efficacy of nivolumab + ipilimumab ± chemotherapy versus pembrolizumab + chemotherapy in patients with PD-L1-negative non-small cell lung cancer (START001 PART-B): a multicenter retrospective observational study.

Journal: Japanese journal of clinical oncology

Published: January 24, 2025

Characteristics, clinical findings, and treatment of idiopathic pulmonary fibrosis in Japanese patients registered with a medical subsidy system for intractable diseases.

Characteristics, clinical findings, and treatment of idiopathic pulmonary fibrosis in Japanese patients registered with a medical subsidy system for intractable diseases.

Journal: Respiratory investigation

Published: December 28, 2024

Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational study.

Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational study.

Journal: Cancer immunology, immunotherapy : CII

Published: August 13, 2024

Detection of fibrosing interstitial lung disease-suspected chest radiographs using a deep learning-based computer-aided detection system: a retrospective, observational study.

Detection of fibrosing interstitial lung disease-suspected chest radiographs using a deep learning-based computer-aided detection system: a retrospective, observational study.

Journal: BMJ open

Published: January 23, 2024

Circulating T follicular helper 2 cells, T follicular regulatory cells and regulatory B cells are effective biomarkers for predicting the response to house dust mite sublingual immunotherapy in patients with allergic respiratory diseases.

Circulating T follicular helper 2 cells, T follicular regulatory cells and regulatory B cells are effective biomarkers for predicting the response to house dust mite sublingual immunotherapy in patients with allergic respiratory diseases.

Journal: Frontiers in immunology

Published: August 28, 2023

Bob1 maintains T follicular helper cells for long-term humoral immunity.

Bob1 maintains T follicular helper cells for long-term humoral immunity.

Journal: Communications biology

Published: July 12, 2023

Management of anti-melanoma differentiation-associated gene 5 antibody-induced refractory dermatomyositis complicated by interstitial pneumonia using tofacitinib and its outcomes: a case report.

Management of anti-melanoma differentiation-associated gene 5 antibody-induced refractory dermatomyositis complicated by interstitial pneumonia using tofacitinib and its outcomes: a case report.

Journal: Journal of medical case reports

Published: June 27, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026